Currently out of the existing stock ratings of David Lewis, 127 are a BUY (58.8%), 6 are a SELL (2.78%), 83 are a HOLD (38.43%).

David Lewis

Work Performance Price Targets & Ratings Chart

Analyst David Lewis, currently employed carries an average stock price target met ratio of 82.83% that have a potential upside of 16.79% achieved within 265 days. Previously, David Lewis worked at MORGAN STANLEY.

David Lewis’s has documented 373 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AXNX, Axonics Modulation Technologies at 31-Oct-2023.

Wall Street Analyst David Lewis

Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for SWAV (SHOCKWAVE MEDICAL) at 4/1/2019. The price target of $32 was fulfilled within 2 days with a profit of $1.53 (4.56%) receiving and performance score of 22.82.

Average potential price target upside

of $45.15 (22.86%) on BDX (BECTON DICKINSON AND COMPANY).
of $38.54 (30.79%) on JNJ (JOHNSON & JOHNSON).
of $33.05 (24.72%) on SWAV (SHOCKWAVE MEDICAL).

ABMD ABIOMED AXNX Axonics Modulation Technologies BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom HOLX Hologic HRC Hill-Rom Holdings IRT Independence Realty Trust ISRG Intuitive Surgical JNJ Johnson & Johnson MDT Medtronic PLC NVRO Nevro Corp PODD Insulet ZBH Zimmer Biomet Holdings EW Edwards Lifesciences Corp ABT Abbott Laboratories NARI Inari Medical SWAV Shockwave Medical HAE Haemonetics LUNG Pulmonx Corp SYK Stryker TMDX TransMedics Group NTLA Intellia Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Pito Chickering (DEUTSCHE BANK)